Catalyst Wire Dossier Catalyst Wire Dossier

MicardisPlus

telmisartan/hydrochlorothiazide · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MicardisPlus, covering 2014-09-17 to 2026-04-28. Get the full timeline:

Most recent: EMA Authorised: MicardisPlus (telmisartan;hydrochlorothiazide) — Boehringer Ingelheim International GmbH

See pricing